Kopin Reports Continued Strong Performance for Fourth Quarter and Fiscal 2021
Kopin Corporation (NASDAQ: KOPN) reported a 14% revenue increase to $45.7 million for 2021, driven by a 41% rise in Industrial/Enterprise revenues and a 120% increase in Consumer revenues for OLED products. Although Q4 revenues fell by 5% due to lower defense product sales, the company highlighted a strong demand for spatial light modulators. A notable achievement was the introduction of All-Plastic Pancake Optics for Metaverse headsets and a 2.6K x 2.6K OLED Display-on-Chip demonstration. The company ended 2021 with a net loss of $13.7 million but maintained a solid cash position with no long-term debt.
- 14% revenue increase year-over-year to $45.7 million in 2021.
- Industrial/Enterprise revenues increased 41% year-over-year.
- Consumer revenues surged 120% year-over-year, driven by OLED product demand.
- Received a follow-on order worth $19.8 million for FWS-I eyepiece subassembly.
- Showcased All-Plastic Pancake Optics for lighter, smaller VR headsets.
- Q4 2021 revenues decreased 5% year-over-year due to lower defense product sales.
- Net loss attributable to controlling interest for 2021 was $13.7 million, up from $4.4 million in 2020.
- SG&A expenses rose by 53.1% year-over-year, indicating growing cost pressures.
-
2021 Revenue
, a$45.7M 14% increase Year Over Year. -
Industrial/Enterprise Revenues Increase
41% Year Over Year on Demand for Spatial Light Modulators. -
Consumer Revenues Increase
120% Year Over Year on Demand for OLED Products. - Strong Growth in Customer-Funded R&D for AR/VR Microdisplays.
- In Q4 announced All-Plastic Pancake Optics for Metaverse headsets.
- Demonstrated 2.6K x 2.6K OLED Display-on-Chip at CES.
“We are pleased with our full year 2021 results, with revenue increasing
“Our defense product line continued to perform well, with full year revenue of
“2021 was both an exciting and challenging year for Kopin. We successfully navigated the global supply chain issues and continued to lead with innovations in display technologies and optics that enable a superior AR and VR experience for the users. In fact, during the fourth quarter we announced what we believe is the world’s first All-Plastic Pancake® Optics with excellent performance that enables smaller, lighter-weight VR and Metaverse headsets. Providing critical components for VR headsets that are thin, lightweight, comfortable and easy to use has been a long-term objective of ours. Previous Pancake optics needed at least one spherical glass lens to avoid image artifacts caused by birefringence of plastic materials, but this spherical glass lens added both weight and cost to the headset as well as reduced optical design flexibilities compared to our aspherical plastic lens. We believe our P95 and new P80 all-plastic Pancake optics, provides better image quality, smaller size, lighter weight and lower cost than anything previously available. To couple with our all-plastic Pancake options, we announced and demonstrated our 1.3” 2.6K x 2.6K OLED Display-on-Chip in January at CES,” said
“We are focused on continuing the growth of our core product lines, as we actively innovate and advance our technology roadmap for AR/VR/MR applications. Interest in the Metaverse continues to be strong, and we believe we are well positioned to capitalize on these opportunities it will create. In 2021, to capture these opportunities, we increased our internal R&D spending, with major focus on Pancake optics and microOLEDs. We also worked with our partners to fund R&D activities on MicroLEDs. We enter 2022 with a very strong backlog of orders and we believe this will be another year of good growth. However, like many companies we continue to deal with supply chain issues, and it is a very dynamic and challenging situation. While we have been very successful to date in preventing shipment disruptions related to the supply chain, we continue to closely monitor the situation. In summary, demands for our products are strong in all sectors, and despite the challenges of Covid, parts shortages, and the process improvements to our FWS-I line, revenue grew
Fourth Quarter Financial Results:
Total revenues for the fourth quarter ended
Cost of product revenues as a percentage of net product revenues for the fourth quarter of 2021 and 2020 were
Research and development (R&D) expenses for the fourth quarter of 2021 were
Selling, general and administrative (SG&A) expenses were
Other income (expense) for the fourth quarter of 2021 and 2020 were income of
The net loss attributable to controlling interest for the fourth quarter of 2021 was
Full Year Results:
Total revenue for the fiscal year ended
Cost of product revenues as a percentage of net product revenues for 2021 and 2020 were
Research and development expenses for 2021 were
Selling, general and administrative expenses were
Other income (expense) for fiscal year 2021 and 2020 were income of
The net loss from controlling interest for the fiscal year ended
Kopin's cash and equivalents and marketable securities were approximately
During 2021, Kopin had 8 new patents granted and filed for 10 new applications. Kopin has over 200 patents, patent applications and/or patents pending, almost all of which are related to wearable applications.
All amounts above are estimates and readers should refer to our Form 10-K for the fiscal year ended
Conference Call
Kopin will host a conference call this morning at
About Kopin:
Pancake and Kopin are registered trademarks and DoC is a trademark of Kopin.
Forward-Looking Statements
Statements in this press release may be considered "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the safe harbor created by such sections. Words such as "expect," "believe," "can," and "will," and variations of such words and similar expressions, and the negatives thereof, are intended to identify such forward-looking statements. We caution readers not to place undue reliance on any such "forward-looking statements," which speak only as of the date made, and advise readers that these forward-looking statements are not guarantees of future performance and involve certain risks, uncertainties, estimates, and assumptions by us that are difficult to predict. These forward-looking statements may include statements with respect to: the magnitude of supply chain issues we may experience and our ability to successfully address and navigate those issues; our belief that the increase in OLED revenues represents continued market traction and progress in developing this new product line; our belief that our growing and robust pipeline of Defense programs in development will continue to drive our defense revenues in the coming years; the timing to ship our
|
||||||||||||
Supplemental Information |
||||||||||||
(Unaudited) |
||||||||||||
Three Months Ended | Twelve Months Ended | |||||||||||
Display Revenues by Category (in millions) | ||||||||||||
Defense | $ |
5.9 |
$ |
7.5 |
$ |
18.2 |
$ |
20.2 |
||||
Industrial/Enterprise |
|
2.3 |
|
1.7 |
|
9.7 |
|
6.9 |
||||
Consumer |
|
0.6 |
|
0.3 |
|
1.9 |
|
0.9 |
||||
Other |
|
- |
|
- |
|
0.1 |
|
0.5 |
||||
R&D |
|
4.3 |
|
3.8 |
|
14.7 |
|
10.1 |
||||
License and Royalties |
|
0.1 |
|
0.7 |
|
1.1 |
|
1.5 |
||||
Total | $ |
13.2 |
$ |
14.0 |
$ |
45.7 |
$ |
40.1 |
||||
Stock-Based Compensation Expense | ||||||||||||
Cost of product revenues | $ |
5,000 |
$ |
42,000 |
$ |
211,000 |
$ |
113,000 |
||||
Research and development |
|
181,000 |
|
11,000 |
|
576,000 |
|
205,000 |
||||
Selling, general and administrative |
|
465,000 |
|
129,000 |
|
3,630,000.0 |
|
503,000 |
||||
$ |
651,000 |
$ |
182,000 |
$ |
4,417,000 |
$ |
821,000 |
|||||
Other Financial Information | ||||||||||||
Depreciation and amortization | $ |
103,000 |
$ |
177,000 |
$ |
669,000 |
$ |
651,000 |
Condensed Consolidated Statements of Operations | ||||||||||||||||
(Unaudited) | ||||||||||||||||
Three Months Ended | Twelve Months Ended | |||||||||||||||
Revenues: | ||||||||||||||||
Net product revenues | $ |
8,792,756 |
|
$ |
9,440,784 |
|
$ |
29,882,271 |
|
$ |
28,517,874 |
|
||||
Research and development revenues |
|
4,304,563 |
|
|
3,828,034 |
|
|
14,668,471 |
|
|
10,122,677 |
|
||||
Other revenues |
|
100,000 |
|
|
652,848 |
|
|
1,115,375 |
|
|
1,487,118 |
|
||||
|
13,197,319 |
|
|
13,921,666 |
|
|
45,666,117 |
|
|
40,127,669 |
|
|||||
Expenses: | ||||||||||||||||
Cost of product revenues |
|
7,465,684 |
|
|
6,145,925 |
|
|
25,052,383 |
|
|
21,398,381 |
|
||||
Research and development |
|
5,232,968 |
|
|
4,393,233 |
|
|
16,288,251 |
|
|
11,670,003 |
|
||||
Selling, general and administration |
|
4,117,838 |
|
|
2,401,679 |
|
|
18,100,519 |
|
|
11,822,703 |
|
||||
|
16,816,490 |
|
|
12,940,837 |
|
|
59,441,153 |
|
|
44,891,087 |
|
|||||
(Loss) income from operations |
|
(3,619,171 |
) |
|
980,829 |
|
|
(13,775,036 |
) |
|
(4,763,418 |
) |
||||
Other income, net |
|
46,399 |
|
|
286,189 |
|
|
135,665 |
|
|
361,493 |
|
||||
Loss before provision for income taxes and net (income) loss from noncontrolling interest |
|
(3,572,772 |
) |
|
1,267,018 |
|
|
(13,639,371 |
) |
|
(4,401,925 |
) |
||||
Tax provision |
|
(32,000 |
) |
|
(29,000 |
) |
|
(129,000 |
) |
|
(129,000 |
) |
||||
Net loss |
|
(3,604,772 |
) |
|
1,238,018 |
|
|
(13,768,371 |
) |
|
(4,530,925 |
) |
||||
Net (income) loss attributable to noncontrolling interest |
|
(3,897 |
) |
|
25,370 |
|
|
35,498 |
|
|
119,813 |
|
||||
Net (loss) income attributable to |
$ |
(3,608,669 |
) |
$ |
1,263,388 |
|
$ |
(13,732,873 |
) |
$ |
(4,411,112 |
) |
||||
Net (loss) income per share: | ||||||||||||||||
Basic | $ |
(0.04 |
) |
$ |
0.02 |
|
$ |
(0.15 |
) |
$ |
(0.05 |
) |
||||
Diluted | $ |
(0.04 |
) |
$ |
0.02 |
|
$ |
(0.15 |
) |
$ |
(0.05 |
) |
||||
Weighted average number of common shares outstanding: | ||||||||||||||||
Basic |
|
88,615,156 |
|
|
81,688,760 |
|
|
88,831,532 |
|
|
82,347,741 |
|
||||
Diluted |
|
88,613,070 |
|
|
82,819,513 |
|
|
88,831,532 |
|
|
82,347,741 |
|
Condensed Consolidated Balance Sheets | ||||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and marketable securities | $ |
29,295,466 |
|
$ |
20,748,550 |
|
||
Accounts receivable, net |
|
12,113,070 |
|
|
9,260,865 |
|
||
Inventory |
|
6,581,139 |
|
|
4,455,756 |
|
||
Contract assets and unbilled receivables |
|
2,299,392 |
|
|
3,521,753 |
|
||
Prepaid and other current assets |
|
1,918,678 |
|
|
1,469,256 |
|
||
Total current assets |
|
52,207,745 |
|
|
39,456,180 |
|
||
Plant and equipment, net |
|
1,888,963 |
|
|
1,626,930 |
|
||
Operating lease right-of-use assets |
|
3,828,066 |
|
|
1,780,039 |
|
||
Equity investments |
|
4,612,022 |
|
|
4,523,525 |
|
||
Other assets |
|
170,932 |
|
|
162,473 |
|
||
Total assets | $ |
62,707,728 |
|
$ |
47,549,147 |
|
||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ |
5,483,970 |
|
$ |
5,606,910 |
|
||
Accrued expenses |
|
4,133,379 |
|
|
4,295,315 |
|
||
Customer deposits |
|
2,638,103 |
|
|
3,950,031 |
|
||
Deferred tax liabilities |
|
513,417 |
|
|
554,031 |
|
||
Contract liabilities and billings in excess of revenue earned |
|
4,063,031 |
|
|
1,493,847 |
|
||
Operating lease liabilities |
|
701,204 |
|
|
982,375 |
|
||
Total current liabilities |
|
17,533,104 |
|
|
16,882,509 |
|
||
Other long term liabilities |
|
2,739,531 |
|
|
1,546,737 |
|
||
Operating lease liabilities, net of current portion |
|
3,108,236 |
|
|
821,306 |
|
||
|
39,499,191 |
|
|
28,435,431 |
|
|||
Noncontrolling interest |
|
(172,334 |
) |
|
(136,836 |
) |
||
Total stockholders' equity |
|
39,326,857 |
|
|
28,298,595 |
|
||
Total liabilities and stockholders' equity | $ |
62,707,728 |
|
$ |
47,549,147 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20220308005492/en/
Investor Contacts
Kopin Investor Relations
CFO rsneider@kopin.com
Or
Jhorne@marketstreetpartners.com
Source:
FAQ
What were Kopin's total revenues for 2021?
How did Kopin's Industrial and Consumer revenues perform in 2021?
What was the net loss for Kopin in the fourth quarter of 2021?
What new technology did Kopin introduce in Q4 2021?